Education related to hepatitis C and HIV and oncology products. International trade and protection of intellectual property; compulsory licensing and other IP issues in multiple countries. Issues related to pharmaceuticals and intellectual property protection including technology transfer, patent rights and funding. Expanding access to HIV treatment and prevention therapies including, Administration proposals; Ryan White Care Act reauthorization; PEPFAR reauthorization; HIV/AIDS access to care, research, testing and treatment. HCV screening and linkage to care programs; coverage and reimbursement policy for HCV, HIV and oncology portfolio. Pharmaceutical policy as it relates to payments under the 340B program. Issues related to developing new treatment for COVID-19 (2019 Novel Coronavirus). 

H.R.6201 - Families First Coronavirus Response Act
H.R.748 / S.3548 - CARES Act 
H.R.3 - Lower Drug Costs Now Act of 2019
S.2543 - Prescription Drug Pricing Reduction Act of 2019
S.3013 - Encouraging Innovate Benefit Design to Lower Costs for Seniors Act Administration drug pricing proposals. HCV testing, screening and linkage to care programs. Medicaid and Medicare coverage, access and reimbursement issues for Hepatitis C, HIV, and oncology products. Medicare Part D reform and benefit redesign. 2021 Notice of Benefit and Payment Parameters (NBPP) proposed rule and CMS rules related to hospital inpatient payments. 

S.2543 - The Prescription Drug Pricing Reduction Act of 2019
S.3129 - Lower Costs, More Cures Act of 2019
H.R.3 - Lower Drug Costs Now Act of 2019 
H.R.19 - Lower Costs, More Cures Act of 2019
H.R.259 - Medicaid Extenders Act of 2019 Administration drug pricing proposals. Funding for HCV, HIV and public health activities via appropriations. H.R. 1865 - Further Consolidated Appropriations Act, 2020
VET - Veterans TRD - Trade (domestic/foreign) CPT - Copyright/Patent/Trademark HCR - Health Issues MMM - Medicare/Medicaid BUD - Budget/Appropriations
134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office 134 - Centers For Disease Control & Prevention (CDC) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 34 - Health & Human Services, Dept of (HHS) 2 - HOUSE OF REPRESENTATIVES 139 - Natl Institutes of Health (NIH) 18 - Office of Management & Budget (OMB) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 12 - White House Office
GILEAD SCIENCES, INC.
333 LAKESIDE DRIVE, FOSTER CITY, CA, 94404, US
DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI DAVID PULLIAM CHARLES M. CLAPTON DAVID PULLIAM CHARLES M. CLAPTON DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI MICHAEL D BOYD ANNA GRIFFIN (Legislative Assistant, Rep. Cass Ballenger; Legislative Assistant, Rep. Howard Coble; Legislative Director, Rep. Howard Coble) DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI MICHAEL D BOYD ANNA GRIFFIN (Legislative Assistant, Rep. Cass Ballenger; Legislative Assistant, Rep. Howard Coble; Legislative Director, Rep. Howard Coble) DAVID PULLIAM CHARLES M. CLAPTON COOKAB HASHEMI
Legislative Assistant, Rep. Cass Ballenger; Legislative Assistant, Rep. Howard Coble; Legislative Director, Rep. Howard Coble Legislative Assistant, Rep. Cass Ballenger; Legislative Assistant, Rep. Howard Coble; Legislative Director, Rep. Howard Coble